Stroke and Bleeding Risks in NOAC- and Warfarin-Treated Patients With Hypertrophic Cardiomyopathy and Atrial Fibrillation

Research output: Contribution to journalLetter

17 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)3020-3021
Number of pages2
JournalJournal of the American College of Cardiology
Volume67
Issue number25
DOIs
StatePublished - Jun 28 2016

Fingerprint

Hypertrophic Cardiomyopathy
Warfarin
Atrial Fibrillation
Stroke
Hemorrhage
N(4)-oleylcytosine arabinoside

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

@article{aec21dfca19141509cea0392abbf4ee6,
title = "Stroke and Bleeding Risks in NOAC- and Warfarin-Treated Patients With Hypertrophic Cardiomyopathy and Atrial Fibrillation",
author = "Peter Noseworthy and Xiaoxi Yao and Shah, {Nilay D} and Gersh, {Bernard J.}",
year = "2016",
month = "6",
day = "28",
doi = "10.1016/j.jacc.2016.04.026",
language = "English (US)",
volume = "67",
pages = "3020--3021",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier USA",
number = "25",

}

TY - JOUR

T1 - Stroke and Bleeding Risks in NOAC- and Warfarin-Treated Patients With Hypertrophic Cardiomyopathy and Atrial Fibrillation

AU - Noseworthy, Peter

AU - Yao, Xiaoxi

AU - Shah, Nilay D

AU - Gersh, Bernard J.

PY - 2016/6/28

Y1 - 2016/6/28

UR - http://www.scopus.com/inward/record.url?scp=84994268375&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84994268375&partnerID=8YFLogxK

U2 - 10.1016/j.jacc.2016.04.026

DO - 10.1016/j.jacc.2016.04.026

M3 - Letter

C2 - 27339501

AN - SCOPUS:84994268375

VL - 67

SP - 3020

EP - 3021

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

SN - 0735-1097

IS - 25

ER -